Inventor · disambiguated record
Stephen J. Farr
Also filed as: FARR STEPHEN · FARR STEPHEN J
33 granted patents·33 pending applications·2,105 citations·filing 1992–2024
98Inventor score
Top patents by PatentIndex Score
66 records- 0199US6167880B1Inhaled insulin dosage control delivery enhanced by controlling total inhaled volumeARADIGM CORP·Filed 1999·Granted Jan 2, 2001·153 cites·11 claims
- 0299US5884620AInhaled insulin dosage control delivery enhanced by controlling total inhaled volumeARADIGM CORP·Filed 1997·Granted Mar 23, 1999·222 cites·20 claims
- 0398US11325882B2Metabolism resistant fenfluramine analogs and methods of using the sameZOGENIX INTERNATIONAL LTD·Filed 2020·Granted May 10, 2022·4 cites·3 claims
- 0498US11040018B2Formulation for inhibiting formation of 5-HT2B agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2020·Granted Jun 22, 2021·10 cites·9 claims
- 0598US7028686B2Inhaled insulin dosage control delivery enhanced by controlling total inhaled volumeARADIGM CORP·Filed 2003·Granted Apr 18, 2006·94 cites·55 claims
- 0698US5888477AUse of monomeric insulin as a means for improving the bioavailability of inhaled insulinARADIGM CORP·Filed 1997·Granted Mar 30, 1999·143 cites·21 claims
- 0797US11673852B2Metabolism resistant fenfluramine analogs and methods of using the sameZOGENIX INTERNATIONAL LTD·Filed 2022·Granted Jun 13, 2023·2 cites·4 claims
- 0897US11406606B2Formulation for inhibiting formation of 5-HT2B agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2022·Granted Aug 9, 2022·5 cites·22 claims
- 0997US5941240AInhaled insulin dosage control delivery enhanced by controlling total inhaled volumeARADIGM CORP·Filed 1998·Granted Aug 24, 1999·98 cites·26 claims
- 1096US11759440B2Formulation for inhibiting formation of 5-HT2B agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2021·Granted Sep 19, 2023·3 cites·10 claims
- 1194US11786487B2Formulation for inhibiting formation of 5-HT2B agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2021·Granted Oct 17, 2023·2 cites·9 claims
- 1294US10603290B2Formulation for inhibiting formation of 5-HT2B agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2018·Granted Mar 31, 2020·10 cites·10 claims
- 1394US5230884AAerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulationsUNIV WALES COLLEGE OF CARDIFF·Filed 1992·Granted Jul 27, 1993·230 cites·36 claims
- 1493US6688304B2Inhaled insulin dosage control delivery enhanced by controlling total inhaled volumeARADIGM CORP·Filed 2001·Granted Feb 10, 2004·44 cites·13 claims
- 1592US9186461B2Viscous formulations and their use in needle-free injectionBOYD BROOKS M·Filed 2012·Granted Nov 17, 2015·14 cites·31 claims
- 1692US8876758B2Viscous formulations and their use in needle-free injectionBOYD BROOKS M·Filed 2011·Granted Nov 4, 2014·13 cites·34 claims
- 1791US7448375B2Method of treating diabetes mellitus in a patientARADIGM CORP·Filed 2005·Granted Nov 11, 2008·72 cites·21 claims
- 1891US6874507B2System for effecting smoking cessationARADIGM CORP·Filed 2004·Granted Apr 5, 2005·62 cites·18 claims
- 1991US6427681B1Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulinARADIGM CORP·Filed 2001·Granted Aug 6, 2002·17 cites·10 claims
- 2091US5292499AMethod of preparing medical aerosol formulations including drug dissolved in reverse micellesUNIV WALES COLLEGE OF CARDIFF·Filed 1992·Granted Mar 8, 1994·142 cites·31 claims
- 2189US8066661B2Viscous formulations and their use in needle-free injectionBOYD BROOKS M·Filed 2008·Granted Nov 29, 2011·14 cites·4 claims
- 2289US6799576B2System for effecting smoking cessationARADIGM CORP·Filed 2002·Granted Oct 5, 2004·123 cites·7 claims
- 2389US6250298B1Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulinARADIGM CORP·Filed 2000·Granted Jun 26, 2001·80 cites·15 claims
- 2485US7278419B2Method for treating diabetes mellitus in a patientNOVO NORDISK AS·Filed 2004·Granted Oct 9, 2007·54 cites·24 claims
- 2584US5829435APrefilter for prevention of clogging of a nozzle in the generation of an aerosol and prevention of administration of undesirable particlesARADIGM CORP·Filed 1997·Granted Nov 3, 1998·99 cites·40 claims
- 2684US2024245631A1Methods of treating lennox-gastaut syndrome using fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2024·Application pending·0 cites
- 2784US2024238222A1Methods of treating lennox-gastaut syndrome using fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2024·Application pending·0 cites
- 2879US6431166B2Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulinARADIGM CORP·Filed 2001·Granted Aug 13, 2002·36 cites·13 claims
- 2978US5829436AVentilation imaging using a fine particle aerosol generatorARADIGM CORP·Filed 1997·Granted Nov 3, 1998·50 cites·7 claims
- 3078US2008264416A1Method of Treating Diabetes Mellitus in a PatientNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 3175US2008102129A1Method of Use of Monomeric Insulin as a Means for Improving the Reproducibility of Inhaled InsulinGONDA IGOR·Filed 2007·Application pending·0 cites
- 3273US7021309B2Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulinARADIGM CORP·Filed 2003·Granted Apr 4, 2006·11 cites·12 claims
- 3372US7490603B2Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulinARADIGM CORP·Filed 2005·Granted Feb 17, 2009·4 cites·19 claims
- 3469US6431167B1Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulinARADIGM CORP·Filed 2001·Granted Aug 13, 2002·18 cites·18 claims
- 3569US6131567AMethod of use of monomeric insulin as a means for improving the reproducibility of inhaled insulinARADIGM CORP·Filed 1998·Granted Oct 17, 2000·126 cites·16 claims
- 3668US6024090AMethod of treating a diabetic patient by aerosolized administration of insulin lisproARADIGM CORP·Filed 1998·Granted Feb 15, 2000·54 cites·10 claims
- 3768US2011118189A1Novel formulations for treatment of migraineFARR STEPHEN J·Filed 2009·Application pending·0 cites
- 3868US2024299317A1Fenfluramine for Treatment of Conditions Associated with Spreading DepolarizationZOGENIX INTERNATIONAL LTD·Filed 2024·Application pending·0 cites
- 3967US2008138397A1Processes for taste-masking of inhaled formulationsARADIGM CORP·Filed 2007·Application pending·0 cites
- 4067US2020253895A1Methods of treating lennox-gastaut syndrome using fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2020·Application pending·0 cites
- 4166US2022226262A1Methods of treating doose syndrome using fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 4266US2023165810A1Fenfluramine for treatment of conditions associated with spreading depolarizationZOGENIX INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 4365US2009241950A1Method of treating diabetes mellitus in a patientARADIGM CORP·Filed 2009·Application pending·0 cites
- 4464US2017056344A1Methods of treating lennox-gastaut syndrome using fenfluramineZOGENIX INT LTD·Filed 2016·Application pending·0 cites
- 4563US2018055789A1Formulation for inhibiting formation of 5-ht2b agonists and methods of using sameZOGENIX INTERNATIONAL LTD·Filed 2017·Application pending·0 cites
- 4662US2014148485A1Novel formulations for treatment of migraneZOGENIX INC·Filed 2014·Application pending·0 cites
- 4761US5792057AVentilation imaging using a fine particle aerosol generatorARADIGM CORP·Filed 1997·Granted Aug 11, 1998·96 cites·20 claims
- 4861US2013231311A1Novel formulations for treatment of migraineZOGENIX INC·Filed 2013·Application pending·0 cites
- 4960US2020170965A1Methods of treating doose syndrome using fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 5056US2016151571A1Novel formulations for treatment of migraineZOGENIX INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen J. Farr files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →